📅Offer Date: 03 Jul 2024 – 05 Jul 2024
Data sourced from BSE & NSE · Last updated
Emcure Pharmaceuticals Limited IPO was subscribed 67.84x in total when bidding closed on 05 Jul 2024, with 195.83x in the QIB category, 48.28x in NII, 7.17x in retail. The issue ran from 03 Jul 2024 to 05 Jul 2024 at a price band of ₹960.00–₹1008.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (7.17x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 38,53,234 | 75,45,78,814 | 195.83x |
| NIIs | 28,89,926 | 13,95,25,627 | 48.28x |
| SNIIs (<10L) | 9,63,309 | 3,58,92,893 | 37.26x |
| BNIIs (>10L) | 19,26,618 | 10,36,32,782 | 53.79x |
| Retail | 67,43,160 | 4,83,48,457 | 7.17x |
| Total | 1,37,03,538 | 92,96,48,018 | 67.84x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 388.41 | 76061.54 | 195.83x |
| NIIs | 291.30 | 14064.18 | 48.28x |
| Retail | 679.71 | 4873.52 | 7.17x |
| Total | 1359.42 | 94999.25 | 67.84x |
Values derived from share count × issue price (₹1008.00)
Because Emcure Pharmaceuticals Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.